Drug intelligence / Profile preview

Venocur Triplex

Development stage
Phase 4
Lead developer
Abbott
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Venocur Triplex is an oral combination drug indicated for the treatment of chronic venous insufficiency, varicose veins, post-thrombotic syndrome, static edema, peripheral circulatory disorders, thrombophlebitis, and for the prophylaxis of thrombosis and embolism in surgical settings. Its active ingredients are Castanha da Índia (horse chestnut extract), Miroton (likely a trade name or specific formulation component), and Rutosídeo (rutoside/rutin). The drug acts primarily as a venotonic and vasoprotective agent—improving venous tone, reducing capillary permeability and fragility, decreasing edema formation, and enhancing microcirculation. It is classified therapeutically as an anti-inflammatory/antivaricose agent. Clinical studies have shown its use in chronic venous insufficiency rated between CEAP 2–4[5][9]. The medication is typically administered orally after meals.

Brand names
Venocur Triplex
Other names
Castanha da Índia + Miroton + Rutosídeo

Beyond the preview

Go deeper on Venocur Triplex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Venocur Triplex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call